BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28685597)

  • 1. Invasive fungal infections: managing the continuum of risk in HCT patients.
    Duarte RF; Lyon S
    Future Microbiol; 2017 Aug; 12():843-846. PubMed ID: 28685597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal prophylaxis: why, what and how?
    Lyon S
    Future Microbiol; 2016; 11(1):11-5. PubMed ID: 26674314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis in haematology patients: the role of voriconazole.
    Hicheri Y; Cook G; Cordonnier C
    Clin Microbiol Infect; 2012 Apr; 18 Suppl 2():1-15. PubMed ID: 22409648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive aspergillosis in the patient with oncohematologic disease].
    Solano C; Vázquez L
    Rev Iberoam Micol; 2018; 35(4):198-205. PubMed ID: 30554673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
    Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
    Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future options for cytomegalovirus reactivation in hematopoietic cell transplantation patients.
    Maertens J; Lyon S
    Future Microbiol; 2017 Aug; 12():839-842. PubMed ID: 28745073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials.
    Lee CH; Lin C; Ho CL; Lin JC
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
    Luu Tran H; Mahmoudjafari Z; Rockey M; Henry D; Grauer D; Aljitawi O; Abhyankar S; Ganguly S; Lin T; McGuirk J
    J Oncol Pharm Pract; 2016 Apr; 22(2):228-34. PubMed ID: 25471252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celebrating 40 years of progress in bone marrow transplantation: a report from the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation.
    Pagano L; Lyon S
    Future Microbiol; 2014; 9(10):1117-21. PubMed ID: 25405881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis for aspergillosis in patients with haematological malignancies: pros and cons.
    Busca A; Pagano L
    Expert Rev Anti Infect Ther; 2018 Jul; 16(7):531-542. PubMed ID: 30033822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal Pneumonia in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation.
    Pergam SA
    Clin Chest Med; 2017 Jun; 38(2):279-294. PubMed ID: 28477639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal Infection.
    Ford ES; Duke ER; Cheng GS; Yoke LM; Liu C; Hill JA; Pergam SA; Pipavath SNJ; Walter RB; Mielcarek M; Schiffer JT; Boeckh M
    Transplant Cell Ther; 2021 Aug; 27(8):684.e1-684.e9. PubMed ID: 33964516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice update of antifungal prophylaxis in immunocompromised children.
    Ramos JT; Romero CA; Belda S; Candel FJ; Carazo Gallego B; Fernández-Polo A; Ferreras Antolín L; Garrido Colino C; Navarro ML; Nef O; Olbright P; Rincón-López E; Ruiz Contreras J; Soler-Palacín P;
    Rev Esp Quimioter; 2019 Oct; 32(5):410-425. PubMed ID: 31507152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Fluconazole Prophylaxis Regimen and the Regimes Chosen by the Patient’s Risk of Fungal Infection in Reducing the Infection Rate after Bone Marrow Transplantation.
    Pourghasemian M; Mehdizadeh M; Hajfathali A; Habibzadeh A; Hosseini MH
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1543-1546. PubMed ID: 29936729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.